454, Roche, NHGRI, New England Biolabs, Integrated Genomics, JGI | GenomeWeb
454 Revenues Increase 43 Percent in Q1 as Unit Awaits Sale to Roche
454 Life Sciences’ first-quarter revenues increased 43 percent compared to the prior-year period, according to information CuraGen disclosed in a filing with the US Securities and Exchange Commission last week.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.